Adhera Therapeutics, Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Adhera Therapeutics, Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $95.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-04-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2022-04-15
- Adhera Therapeutics, Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2020 was $95.00K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2020-12-31 | $95.00K 10-K · filed 2022-04-15 |